EPS consensus revisions : last 18 months |
|
|
Next year EPS consensus revisions : last 18 months |
|
|
Revenue consensus revisions : last 18 months |
|
|
Next year Revenue consensus revisions : last 18 months |
|
|
Financial data source © 2021 S&P Global Market Intelligence
|
|
|
Merck to move COVID-19 treatment into large trials, sees sales recovering this year |
|
MERCK AND COMPANY Leader in oncology, modest valuation |
|